ArticleFrontiers in public health2025
Global trends and risk factors of chronic kidney disease in children and young adults from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Family management adjustment and quality of life in adolescents with chronic kidney disease: the mediating role of healthcare transition readiness.Pediatric nephrology (Berlin, Germany) · 2026Article
- Beyond paediatric nephrology: gaps in care for young adults.Nature reviews. Nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic kidney disease (CKD) is an important contributor to morbidity and mortality from non-communicable disease in children and young adults, but there is a lack of data on incidence, mortality, disability-adjusted life years (DALYs), risk factors, and trends in this population. This study aims to provide comprehensive estimates of the burden of CKD among children and young adults. Methods: We conducted a trend analysis using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. Measures of burden at the global, sociodemographic index (SDI), and regional levels for children and young adults included incidence, mortality, and DALY rates per 100,000 population due to CKD, as well as attributable risks of death and DALYs, the annual percentage change (APC), and the average annual percentage change (AAPC). We also investigated the association between CKD burden and SDI and predicted the incidence from 2022 to 2050. Results: Globally, from 1990 to 2021, children with CKD demonstrated declining trends in mortality and DALYs, with AAPCs of -1.925 and -1.820, respectively; however, the incidence rate did not change significantly, although it showed a negative trend overall (AAPCs: -0.095). Conversely, all three metrics showed upward trajectories in young adults, with AAPCs of 0.941, 0.256, and 0.187. The relationship between incidence and SDI exhibited an inverse U-shaped pattern, while also demonstrating significant negative associations with mortality and DALYs. Notably, region-specific disparities emerged in attributable risk factors for mortality and DALYs among young adults. Higher SDI regions displayed greater proportional contributions from high fasting plasma glucose, high body mass index, and diets high in processed meat and red meat. Projections for 2022-2050 suggest a continued reduction in children's CKD incidence, while projections for young adults' incidence suggest a continued increase. Conclusion: The global burden of CKD shows divergent trends across age groups, with projected increases among young adults contrasting with projected declines among children. Lower SDI regions demonstrate a disproportionately higher burden of CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.